The idea that the lows of December could be retested now seems far-fetched.
Consider straddles for this battleground stock.
From small-cap genetics and biotech firms to large-cap drug distributors and pharmacies, eight experts select their top picks in the space for this year.
We have a gap-up open and some poor earnings news -- and once again the bears are on the run as they keep trying to guess when a turn will occur.
Banks' quarterly reports mean quarterly grades are due.
Signet's slide has signals for Tiffany shareholders.
The long-term demand bolstered by secular shifts in technology are keeping many onboard the ship for semiconductors in the long term.
This should be a triple-top, in theory, but since they don't exist…
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.